Condition: Acute Decompensated Heart Failure · Sponsor: Universitas Diponegoro
Based on ADVOR trial, the potential of adding acetazolamide in increasing the success of decongestion, the amount of natriuresis and diuresis. However, the use of intravenous acetazolamide may not be possible in Indonesia, where the intravenous formulation is not available. This clinical research study is being conducted in single hospitals in Indonesia. We aim to learn if Oral Acetazolamide in addition to Furosemide intravenous works to treat congestion in Acute Decompensated Heart Failure, besides evaluating the total urinary output, change of NT pro BNP level, and safety profile of oral Acetazolamide. The hypothesis of this study is oral acetazolamide works well to achieve successful decongestion.
This description comes directly from the study's public registry record.
Inne P Farissa, MD · 024-8413476 · innefarissa@gmail.com
Tahari B Prakoso, MD · 024-8413476 · ibas_tbargasp@yahoo.com
Always discuss trial participation with your own doctor first.
| Department of Cardiology and Vascular Medicine, Universitas Diponegoro, Kariadi Central General Hospital | Semarang, Central Java, Indonesia | Recruiting |
| Kariadi Central General Hospital | Semarang, Central Java, Indonesia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06475105